tiprankstipranks
Advertisement
Advertisement

HK:2500 Stock Latest News

Venus Medtech Schedules Board Meeting to Approve 2026 Interim Results
Company AnnouncementsVenus Medtech Schedules Board Meeting to Approve 2026 Interim Results
7d ago
2500
Venus Medtech Subscription Deal Lapses as Company Pursues New Financing Plan
PremiumCompany Announcements
Venus Medtech Subscription Deal Lapses as Company Pursues New Financing Plan
2M ago
2500
Venus Medtech Explores Up to RMB500 Million Investment via Shares and Convertible Bonds
PremiumCompany Announcements
Venus Medtech Explores Up to RMB500 Million Investment via Shares and Convertible Bonds
2M ago
2500
Venus Medtech Wins Shareholder Backing for All 2025 AGM Resolutions
PremiumCompany Announcements
Venus Medtech Wins Shareholder Backing for All 2025 AGM Resolutions
2M ago
2500
Venus Medtech Sets 2025 AGM to Approve Reports, Profit Plan and Capital Mandates
PremiumCompany Announcements
Venus Medtech Sets 2025 AGM to Approve Reports, Profit Plan and Capital Mandates
3M ago
2500
Venus Medtech Executive Director Resigns, Board Signals Smooth Transition
PremiumCompany AnnouncementsVenus Medtech Executive Director Resigns, Board Signals Smooth Transition
3M ago
2500
Venus Medtech Outlines Board and Committee Roles to Strengthen Governance
Premium
Company Announcements
Venus Medtech Outlines Board and Committee Roles to Strengthen Governance
3M ago
2500
Venus Medtech Announces Change of Company Secretary and Authorized Representatives
Premium
Company Announcements
Venus Medtech Announces Change of Company Secretary and Authorized Representatives
4M ago
2500
Venus Medtech Narrows Losses but Revenue and Margins Slide in 2025
PremiumCompany Announcements
Venus Medtech Narrows Losses but Revenue and Margins Slide in 2025
5M ago
2500
Venus Medtech Schedules Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Venus Medtech Schedules Board Meeting to Approve 2025 Annual Results
5M ago
2500
Venus Medtech Flags U.S. Patent Suit Over Heart Valve Technology Targeting Edwards Lifesciences
PremiumCompany Announcements
Venus Medtech Flags U.S. Patent Suit Over Heart Valve Technology Targeting Edwards Lifesciences
7M ago
2500
Venus Medtech Clarifies Position on U.S. Patent Lawsuit and Market Disclosure Obligations
PremiumCompany Announcements
Venus Medtech Clarifies Position on U.S. Patent Lawsuit and Market Disclosure Obligations
7M ago
2500
Venus Medtech to Exit Investee Company with US$15 Million Share Disposal
PremiumCompany AnnouncementsVenus Medtech to Exit Investee Company with US$15 Million Share Disposal
8M ago
2500
Venus Medtech Files CE MDR Application for Cardiovalve Tricuspid Replacement System
Premium
Company Announcements
Venus Medtech Files CE MDR Application for Cardiovalve Tricuspid Replacement System
8M ago
2500
Venus Medtech Approves Key Resolution at Extraordinary General Meeting
Premium
Company Announcements
Venus Medtech Approves Key Resolution at Extraordinary General Meeting
9M ago
2500
Venus Medtech Reports Promising Interim Results for Cardiovalve Study
PremiumCompany Announcements
Venus Medtech Reports Promising Interim Results for Cardiovalve Study
9M ago
2500
Venus Medtech Announces Convertible Bonds Issuance to Boost Product Development
PremiumCompany Announcements
Venus Medtech Announces Convertible Bonds Issuance to Boost Product Development
9M ago
2500
Venus Medtech Announces EGM for Disposal Agreement Approval
PremiumCompany Announcements
Venus Medtech Announces EGM for Disposal Agreement Approval
10M ago
2500
Venus Medtech Sells Industrial Park Property to Refocus on Core Business
PremiumCompany Announcements
Venus Medtech Sells Industrial Park Property to Refocus on Core Business
10M ago
2500
Venus Medtech Completes Patient Enrollment for Cardiovalve Study in Europe
PremiumCompany AnnouncementsVenus Medtech Completes Patient Enrollment for Cardiovalve Study in Europe
10M ago
2500
Venus Medtech Reports Interim Financial Results Amid Revenue Decline
Premium
Company Announcements
Venus Medtech Reports Interim Financial Results Amid Revenue Decline
12M ago
2500
Venus Medtech Schedules Board Meeting to Review Interim Results
Premium
Company Announcements
Venus Medtech Schedules Board Meeting to Review Interim Results
1y ago
2500

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >